Cargando…

ODP259 Evaluating the Efficacy and Safety of Long-Acting GLP-1 Receptor Agonist in T1DM Patients

INTRODUCTION: GLP-1 receptor agonist is a medication class that mimics the endogenous incretin hormone GLP-1. Short-acting GLP-1 agents were studied as adjunct therapies in type 1 diabetes (T1DM) but not approved due to concern of increased diabetic ketoacidosis (DKA) risk. Long-acting GLP-1 medicat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohandas, Deene, Gao, Catherine, Calma, Jamie, Basina, Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Diabetes & Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628966/ http://dx.doi.org/10.1210/jendso/bvac150.706

Ejemplares similares

Covid Lockdown Impact on Type 1 Diabetes Health and Well-Being
por: Calma, Jamie, et al.
Publicado: (2021)

ODP171 Choosing GLP-1RA Over Insulin for Patients with Type 2 Diabetes and Severe Hyperglycemia
por: Mamtani, Raashi, et al.
Publicado: (2022)

ODP183 Diabetic Ketoacidosis Precipitated by Ketogenic Diet and SGLT-2 Inhibitor Use in an Individual with T2DM
por: Mason, Timothy, et al.
Publicado: (2022)

FRI657 Case Series On GLP-1 Receptor Agonist Related Acute Pancreatitis
por: Kumar Kulkarni, Abhigna Uday, et al.
Publicado: (2023)

THU334 Trends In GLP-1 Agonist Utilization In Diabetics With And Without Vascular Disease
por: Sargin, Pinar, et al.
Publicado: (2023)

RF04 | PSUN295 Evolution of Monomeric Multi-Agonists of GLP-1 and NPY Receptors
por: Chichura, Kylie, et al.
Publicado: (2022)

FRI652 Type 2 Diabetes Management: More GLP1 Agonists And Less Metformin?
por: Lopez Maldonado, Francisco J, et al.
Publicado: (2023)

PSUN259 A Severe Case of Fournier's Gangrene Associated With Dapagliflozin
por: Syed, Shumail, et al.
Publicado: (2022)

ODP227 Nivolumab Induced Type 1 Diabetes
por: Lim, Jonea, et al.
Publicado: (2022)

THU259 Alpelisib-induced Diabetic Ketoacidosis: Call For A Multidisciplinary Approach
por: Kalara, Niketa, et al.
Publicado: (2023)

RF28 | PSUN182 Risk of Pancreatitis After Glp-1 Receptor Agonist in Individuals With Known History of Pancreatitis
por: Kodali, Alimitha M, et al.
Publicado: (2022)

PSUN192 Therapeutic Benefit of GLP-1 Agonists in Patients with Type 1 Diabetes on Insulin Therapy: an Updated Systematic Review and Meta-analysis
por: Park, Jeayoung, et al.
Publicado: (2022)

PSUN172 Prescribing SGLT-2 Inhibitors and GLP-1 Agonists in Primary Care: Improving Rates of Guideline-Concordant Practice
por: Schuetz, Samantha, et al.
Publicado: (2022)

ODP202 Geriatric Type 1 Diabetes- unique management challenge
por: Patel, Toral, et al.
Publicado: (2022)

THU275 Tacrolimus Levels And Kidney Function In Kidney Transplanted (KT) Patients With Diabetes On Glucagon Like-1 Receptor Agonists (GLP1-RA)
por: Campana, Mario S, et al.
Publicado: (2023)

Management of Late Dumping Syndrome Induced Hypoglycemia With GLP-1R Agonist
por: Shaghouli, Amna Ali, et al.
Publicado: (2021)

PSUN188 Evaluating Response to GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Managed at a Veterans Affairs Hospital
por: Davis, Clifton, et al.
Publicado: (2022)

ODP260 New Type of Autoimmune Diabetes
por: Kumar, Surina, et al.
Publicado: (2022)

ODP165 Atypical DKA? Think Cannabis!
por: Albashaireh, Arwa, et al.
Publicado: (2022)

ODP242 Safety of SGLT2-Inhibitors in Patients with Multiple Myeloma and Diabetes
por: Shyu, Margaret, et al.
Publicado: (2022)

ODP206 High Burden of Chronic Kidney Disease in Young Adults with Type 1 Diabetes
por: Favel, Kristen, et al.
Publicado: (2022)

ODP169 Challenges with use of HbA1C for Evaluation of Blood Glucose Control
por: Maletkovic, Jelena
Publicado: (2022)

ODP234 Proposal for an Inclusive Diabetes Education Program in Regional Schools
por: Zappala, Renata Francioni L, et al.
Publicado: (2022)

Do GLP-1 Receptor Agonists Increase the Risk of Breast Cancer? A Systematic Review and Meta-Analysis
por: Piccoli, Giovana Fagundes, et al.
Publicado: (2021)

Psychological Impact of Diabetes Technology on Type 1 Diabetes Pregnancy
por: Less, Jacob, et al.
Publicado: (2021)

ODP201 Fyn regulates sarcopenia via autophagy
por: Yamada, Eijiro, et al.
Publicado: (2022)

ODP186 Difficulties in diagnosing MODY: clinical case
por: Volkova, Natalya, et al.
Publicado: (2022)

ODP216 Interventional Study To Reduce The Readmission Rate In Type 1 Diabetics Hospitalized For Diabetic Ketoacidosis
por: Hashmi, Syed Salman Hamid, et al.
Publicado: (2022)

THU264 Enteric Activity Enhanced Ileal GLP-1 Secretion
por: Chen, Yixin, et al.
Publicado: (2023)

ODP254 WFS1 Loss of Function Causes ER Stress-Mediated Inflammation in Pancreatic β-Cells
por: Morikawa, Shuntaro, et al.
Publicado: (2022)

ODP204 Hemochromatosis and endocrine dysfunctions – a case report
por: Carvalho, Davide, et al.
Publicado: (2022)

ODP182 Diabetes types and risk of severe COVID-19
por: Kazlauskaite, Rasa, et al.
Publicado: (2022)

ODP180 Diabetes Apps: Do They Help Our Patients?
por: Xia, Alexander, et al.
Publicado: (2022)

ODP214 INSULIN REQUIRING DIABETES MELLITUS(IRDM) and CAD
por: Singh, Santosh
Publicado: (2022)

ODP157 A Case of Pancreatic Insulinoma With Hypoglycemia Unawareneness
por: Reda, Sarah A, et al.
Publicado: (2022)

MON-LB028 Comparing Cardiovascular Effects of GLP-1 Agonists in a Real World Setting
por: Wallia, Amisha, et al.
Publicado: (2019)

MON-646 Novel Use of GLP-1 Receptor Agonist Therapy in MODY-1 (HNF4A Mutation)
por: Broome, David Tyler, et al.
Publicado: (2020)

ODP258 CRHR1 gene shows extensive linkage to major depression and type 2 diabetes in Italian families
por: Amin, Mutaz, et al.
Publicado: (2022)

ODP163 Association of HbA1c and Comfort with Diabetes Self-Management Among Adolescents and Young Adults with Type 1 Diabetes
por: Onwukwe, Obichi, et al.
Publicado: (2022)

ODP213 Insulin Autoimmune Syndrome a rare case report
por: Paladugu, Sridevi
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vmu30ao1ksm4k5lf1ucnecumuu